Literature DB >> 23586622

Lipopolysaccharide of Aggregatibacter actinomycetemcomitans up-regulates inflammatory cytokines, prostaglandin E2 synthesis and osteoclast formation in interleukin-1 receptor antagonist-deficient mice.

H Mizutani1, Y Ishihara, A Izawa, Y Fujihara, S Kobayashi, H Gotou, E Okabe, H Takeda, Y Ozawa, Y Kamiya, H Kamei, T Kikuchi, G Yamamoto, A Mitani, T Nishihara, T Noguchi.   

Abstract

BACKGROUND AND
OBJECTIVE: The interleukin (IL)-1 receptor antagonist (Ra) binds to IL-1 receptors and inhibits IL-1 activity. However, it is unclear whether the IL-1Ra plays a protective role in periodontal disease. The purpose of this study was to compare IL-1Ra knockout (KO) and wild-type (WT) mice in regard to proinflammatory cytokine production, osteoclast formation and bone resorption in response to periodontal bacterial lipopolysaccharide (LPS).
MATERIAL AND METHODS: Peritoneal macrophages (Mφs) were obtained from 13-wk-old IL-1Ra KO and WT mice. Peritoneal Mφs were cultured with or without 10 μg/mL of Aggregatibacter actinomycetemcomitans LPS for 24 h. The levels of IL-1alpha (IL-1α), IL-1beta (IL-1β), tumor necrosis factor-α (TNF-α) and IL-6 were measured in periotoneal Mφs supernatant fluid (PM-SF) using an ELISA. Bone marrow cells were obtained from the mice and stimulated with PM-SF for 9 d, then stained with TRAP. The frequency of TRAP-positive multinucleated giant cell formation was calculated based on a fusion index. PM-SF-stimulated calvarial bone resorption was analyzed using micro-computed tomography, and calvarial histological analysis was performed using hematoxylin and eosin and TRAP staining. The expression of cyclooxygenase-2 (Cox2), prostanoid receptor EP4 (Ep4) and Rank mRNAs in bone marrow cells were measured using real-time quantitative PCR, while prostaglandin E2 (PGE2 ) production was determined by ELISA.
RESULTS: The levels of IL-1α, IL-1β, TNF-α and IL-6 in IL-1Ra KO mice PM-SF stimulated with A. actinomycetemcomitans LPS were significantly increased by approximately 4- (p < 0.05), 5- (p < 0.05), 1.3- (p < 0.05) and 6- (p < 0.05) fold, respectively, compared with the levels in WT mice. Moreover, osteoclast formation, expression of Rank, Ep4 and Cox2 mRNAs and production of PGE2 were significantly increased by approximately 2- (p < 0.05), 1.6- (p < 0.05), 2.5- (p < 0.05), 1.6- (p < 0.05) and 1.9- (p < 0.05) fold, respectively, in IL-1Ra KO mice stimulated with A. actinomycetemcomitans LPS compared with WT mice.
CONCLUSION: IL-1Ra regulates IL-1 activity and appears to reduce the levels of other inflammatory cytokines, including TNF-α and IL-6, while it also reduces expression of the EP4 receptor related to prostanoid sensitivity and osteoclast formation. These results suggest that IL-1Ra is an important molecule for inhibition of inflammatory periodontal bone resorption.
© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  cyclooxygenase-2; periodontal disease; prostaglandin E2; prostanoid receptor EP4

Mesh:

Substances:

Year:  2013        PMID: 23586622     DOI: 10.1111/jre.12065

Source DB:  PubMed          Journal:  J Periodontal Res        ISSN: 0022-3484            Impact factor:   4.419


  11 in total

1.  Inflammatory bone loss in experimental periodontitis induced by Aggregatibacter actinomycetemcomitans in interleukin-1 receptor antagonist knockout mice.

Authors:  A Izawa; Y Ishihara; H Mizutani; S Kobayashi; H Goto; E Okabe; H Takeda; Y Ozawa; Y Kamiya; Y Sugita; K Kubo; H Kamei; T Kikuchi; A Mitani; J Hayashi; T Nishihara; H Maeda; T Noguchi
Journal:  Infect Immun       Date:  2014-02-24       Impact factor: 3.441

2.  Role of interleukin-1 receptor signaling in the behavioral effects of ethanol and benzodiazepines.

Authors:  Yuri A Blednov; Jillian M Benavidez; Mendy Black; Jody Mayfield; R Adron Harris
Journal:  Neuropharmacology       Date:  2015-04-01       Impact factor: 5.250

3.  Acyloxyacyl hydrolase deficiency induces chronic inflammation and bone loss in male mice.

Authors:  Xu Cheng; Xiaoting Song; Zhiyan Li; Chiting Yuan; Xinhuan Lei; Mingxuan Feng; Zhenghua Hong; Liwei Zhang; Dun Hong
Journal:  J Mol Med (Berl)       Date:  2022-09-16       Impact factor: 5.606

4.  Gongronema latifolium leaf extract modulates hyperglycaemia, inhibits redox imbalance and inflammation in alloxan-induced diabetic nephropathy.

Authors:  Oluwafemi Adeleke Ojo; Olukemi Adetutu Osukoya; Lisa Ilobekemen Ekakitie; Basiru Olaitan Ajiboye; Babatunji Emmanuel Oyinloye; Precious Eseose Agboinghale; Abidemi Paul Kappo
Journal:  J Diabetes Metab Disord       Date:  2020-05-12

Review 5.  The role of osteoimmunology in periodontal disease.

Authors:  Rayyan A Kayal
Journal:  Biomed Res Int       Date:  2013-09-17       Impact factor: 3.411

6.  Interleukin-1 Receptor Antagonist Has a Novel Function in the Regulation of Matrix Metalloproteinase-13 Expression.

Authors:  Hisashi Goto; Yuichi Ishihara; Takeshi Kikuchi; Ario Izawa; Nobuaki Ozeki; Eijiro Okabe; Yosuke Kamiya; Yusuke Ozawa; Hiroki Mizutani; Genta Yamamoto; Makio Mogi; Kazuhiko Nakata; Hatsuhiko Maeda; Toshihide Noguchi; Akio Mitani
Journal:  PLoS One       Date:  2015-10-16       Impact factor: 3.240

Review 7.  Role of Muramyl Dipeptide in Lipopolysaccharide-Mediated Biological Activity and Osteoclast Activity.

Authors:  Hideki Kitaura; Masahiko Ishida; Keisuke Kimura; Haruki Sugisawa; Akiko Kishikawa; Kazuhiro Shima; Saika Ogawa; Jiawei Qi; Wei-Ren Shen
Journal:  Anal Cell Pathol (Amst)       Date:  2018-02-14       Impact factor: 2.916

8.  Increase in the Number of Bone Marrow Osteoclast Precursors at Different Skeletal Sites, Particularly in Long Bone and Jaw Marrow in Mice Lacking IL-1RA.

Authors:  Giuliana Ascone; Yixuan Cao; Ineke D C Jansen; Irene Di Ceglie; Martijn H J van den Bosch; Arjen B Blom; Peter L E M van Lent; Vincent Everts; Teun J de Vries
Journal:  Int J Mol Sci       Date:  2020-05-27       Impact factor: 5.923

Review 9.  Overview of RAW264.7 for osteoclastogensis study: Phenotype and stimuli.

Authors:  Lingbo Kong; Wanli Smith; Dingjun Hao
Journal:  J Cell Mol Med       Date:  2019-03-20       Impact factor: 5.310

10.  Magnesium Lithospermate B Protects against Lipopolysaccharide-Induced Bone Loss by Inhibiting RANKL/RANK Pathway.

Authors:  Jihai Wang; Xuejian Wu; Yongzhuang Duan
Journal:  Front Pharmacol       Date:  2018-02-06       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.